Re: Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone.
暂无分享，去创建一个
[1] Steven L. Chang,et al. Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Kantoff,et al. Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade , 2018, Prostate Cancer and Prostatic Diseases.
[3] P. Kantoff,et al. Neoadjuvant Enzalutamide Prior to Prostatectomy , 2016, Clinical Cancer Research.
[4] J. Richie,et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] T. Wilt,et al. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. , 2009, Cancer treatment reviews.